Toolkit/organoids

organoids

Construct Pattern·Research·Since 2018

Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

Today, organoids derived from either adult stem cells or pluripotent stem cells can be grown to resemble various organs. As they are similar to their original organs, organoids hold great promise for use in medical research and the development of new treatments.

Usefulness & Problems

Why this is useful

Organoids are stem-cell-derived 3D organ-like models that can be grown to resemble various organs. The review frames them as a current organoid technology platform for research and treatment development.; medical research; disease modeling; drug development; personalized treatment; regenerative medicine

Source:

Organoids are stem-cell-derived 3D organ-like models that can be grown to resemble various organs. The review frames them as a current organoid technology platform for research and treatment development.

Source:

medical research

Source:

disease modeling

Source:

drug development

Source:

personalized treatment

Source:

regenerative medicine

Problem solved

They provide organ-resembling models for basic research, disease modeling, drug development, personalized treatment, and regenerative medicine. The review also notes clinical use enabling personalized medicine for inflammatory bowel disease.; providing organ-like in vitro models derived from stem cells; supporting research and treatment-development applications with models that resemble original organs

Source:

They provide organ-resembling models for basic research, disease modeling, drug development, personalized treatment, and regenerative medicine. The review also notes clinical use enabling personalized medicine for inflammatory bowel disease.

Source:

providing organ-like in vitro models derived from stem cells

Source:

supporting research and treatment-development applications with models that resemble original organs

Problem links

providing organ-like in vitro models derived from stem cells

Literature

They provide organ-resembling models for basic research, disease modeling, drug development, personalized treatment, and regenerative medicine. The review also notes clinical use enabling personalized medicine for inflammatory bowel disease.

Source:

They provide organ-resembling models for basic research, disease modeling, drug development, personalized treatment, and regenerative medicine. The review also notes clinical use enabling personalized medicine for inflammatory bowel disease.

supporting research and treatment-development applications with models that resemble original organs

Literature

They provide organ-resembling models for basic research, disease modeling, drug development, personalized treatment, and regenerative medicine. The review also notes clinical use enabling personalized medicine for inflammatory bowel disease.

Source:

They provide organ-resembling models for basic research, disease modeling, drug development, personalized treatment, and regenerative medicine. The review also notes clinical use enabling personalized medicine for inflammatory bowel disease.

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Architecture: A reusable architecture pattern for arranging parts into an engineered system.

Techniques

No technique tags yet.

Target processes

No target processes tagged yet.

Input: Chemical

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: actuator

The abstract states that organoids are derived from either adult stem cells or pluripotent stem cells. No additional culture components or assay requirements are specified in the provided text.; requires derivation from adult stem cells or pluripotent stem cells

Independent follow-up evidence is still limited. Validation breadth across biological contexts is still narrow. Independent reuse still looks limited, so the evidence base may be fragile. No canonical validation observations are stored yet, so context-specific performance remains under-specified.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1application summarysupports2018Source 1needs review

Because organoids are similar to their original organs, they hold promise for medical research and the development of new treatments.

Claim 2capability summarysupports2018Source 1needs review

Organoids derived from adult stem cells or pluripotent stem cells can be grown to resemble various organs.

Claim 3clinical translation summarysupports2018Source 1needs review

Organoids have already been utilized in the clinic, enabling personalized medicine for inflammatory bowel disease.

Claim 4review scope summarysupports2018Source 1needs review

The review summarizes applications of organoids in basic research, disease modeling, drug development, personalized treatment, and regenerative medicine.

Approval Evidence

1 source4 linked approval claimsfirst-pass slug organoids
Today, organoids derived from either adult stem cells or pluripotent stem cells can be grown to resemble various organs. As they are similar to their original organs, organoids hold great promise for use in medical research and the development of new treatments.

Source:

application summarysupports

Because organoids are similar to their original organs, they hold promise for medical research and the development of new treatments.

Source:

capability summarysupports

Organoids derived from adult stem cells or pluripotent stem cells can be grown to resemble various organs.

Source:

clinical translation summarysupports

Organoids have already been utilized in the clinic, enabling personalized medicine for inflammatory bowel disease.

Source:

review scope summarysupports

The review summarizes applications of organoids in basic research, disease modeling, drug development, personalized treatment, and regenerative medicine.

Source:

Comparisons

Source-stated alternatives

The provided abstract does not explicitly discuss alternative model systems.

Source:

The provided abstract does not explicitly discuss alternative model systems.

Source-backed strengths

can be grown to resemble various organs; similar to their original organs; already utilized in the clinic for personalized medicine in inflammatory bowel disease

Source:

can be grown to resemble various organs

Source:

similar to their original organs

Source:

already utilized in the clinic for personalized medicine in inflammatory bowel disease

Compared with bacterial degrons

organoids and bacterial degrons address a similar problem space.

Shared frame: same top-level item type; same primary input modality: chemical

organoids and hemisynthetic thiostrepton analogues address a similar problem space.

Shared frame: same top-level item type; same primary input modality: chemical

Compared with rM3Ds

organoids and rM3Ds address a similar problem space.

Shared frame: same top-level item type; same primary input modality: chemical

Ranked Citations

  1. 1.
    StructuralSource 1The Annual Review of Pharmacology and Toxicology2018Claim 1Claim 2Claim 3

    Seeded from load plan for claim cl1. Extracted from this source document.